Talamonti, M. (2021) “Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study”, Acta Dermato-Venereologica, 101(3), p. adv00422. doi: 10.2340/00015555-3712.